Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhangjiakou Pharmaceutical Group is a major Chinese pharmaceutical manufacturer and a key subsidiary of CSPC Pharmaceutical Group. Founded in 1946 and based in Zhangjiakou, Hebei, the company has grown into a significant production hub for active pharmaceutical ingredients (APIs) and finished dosage forms. It is particularly well-known for its large-scale production of antibiotics and Vitamin C, serving both domestic and international markets. The company's facilities are equipped with advanced manufacturing technology and adhere to rigorous international GMP standards. As an integral part of the CSPC network, it leverages the parent company's extensive R&D capabilities and global distribution channels. Its product portfolio spans multiple therapeutic areas, including anti-infectives, cardiovascular health, and nutritional supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhangjiakou Pharmaceutical Group.